Frontiers in Endocrinology (May 2023)

Sporadic parathyroid adenoma: an updated review of molecular genetics

  • Angeliki Chorti,
  • Angeliki Cheva,
  • Anthoula Chatzikyriakidou,
  • Charoula Achilla,
  • Kassiani Boulogeorgou,
  • Krokou Despoina,
  • Stefanos Milias,
  • Thomas Zarampoukas,
  • Theodossis Papavramidis,
  • Theodossis Papavramidis

DOI
https://doi.org/10.3389/fendo.2023.1180211
Journal volume & issue
Vol. 14

Abstract

Read online

IntroductionPrimary HPT (PHPT) is a common disorder, affecting approximately 1% of the general population. Parathyroid adenomas emerge as non-familial sporadic in 90% of cases. The aim of this review is to give a detailed update of molecular genetics of sporadic parathyroid adenoma reported in international literature.MethodsA bibliographic research was conducted in PubMed, Google Scholar, and Scopus.ResultsSeventy-eight articles were included in our review. CaSR, MEN1, CCND1/PRAD, CDKI, angiogenic factors like VEGF, FGF, TGFβ, and IGF1, and apoptotic factors are important genes in parathyroid adenomas pathogenesis that have been established by several studies. A huge list of proteins is differently expressed in parathyroid adenomas measured by Western Blotting, MALDI/TOF, MS spectrometry, and immunohistochemistry. These proteins take part in several cell processes such as cell metabolism, cytoskeleton structural stability, cell oxidative stress regulation, cell death, transcription, translation, cell connection, and cell signaling transmission, while they can be found over- or underexpressed in abnormal tissues.ConclusionThis review gives a detailed analysis of all reported data on genomics and proteomics of parathyroid adenoma. Further studies should be applied on understanding parathyroid adenoma pathogenesis and introducing new biomarkers for early detection of primary hyperparathyroidism.

Keywords